Pioneer Acquisition I Corp Warr (NASDAQ:PACHW)
| Market Cap | $95.05M-76.6% |
| Revenue (ttm) | $0 |
| Net Income | $8.86M+240903.5% |
| EPS | $0.35+5503.2% |
| Shares Out | 28.44M |
| PE Ratio | 28.01 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15 |
| Open | $0.07 |
| Previous Close | $0.10 |
| Day's Range | $0.07 - $0.07 |
| 52-Week Range | $0.07 - $0.30 |
| Beta | 2.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PACHW
Pioneer Acquisition I Corp's primary objective is to engage in strategic business combinations, including but not limited to mergers, asset or share acquisitions, or corporate reorganizations, with one or more entities operating within the healthcare industry or related fields. The firm was founded in 2024 and maintains its headquarters in Brooklyn, New York.
$PACHW stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in PACHW holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PACHW's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PACHW Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PACHW Revenue by Segment
| Investments held in Trust Account | $262.91M | 98.92% |
| Interest earned on investments held in Trust Account | $2.31M | 0.87% |
| Cash and cash equivalents | $468.67K | 0.18% |
| Prepaid insurance | $85.59K | 0.03% |
| Other income | $4.51K | 0.00% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PACHW patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PACHW from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from PACHW’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.